On April 30, 2024, the US Department of Justice recommended that cannabis be rescheduled as a Schedule III controlled substance, a classification shared by prescription drugs such as ketamine and Tylenol with codeine....more
5/16/2024
/ Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Justice (DOJ) ,
Dispensaries ,
Internal Revenue Code (IRC) ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
OMB ,
Schedule I Drugs